期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 64, 期 14, 页码 9639-9648出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.1c00293
关键词
-
资金
- Ministry of Education, Science and Technological Development of the Republic of Serbia [451-03-68/2020-14/200113]
- Faculty of Medicine of the University of Nis [40]
This study classifies approved and potent DPP-4 inhibitors with gliptin-like structures into three groups based on their structures and mechanisms of inhibition, showing different binding modes in various domains of the enzyme. The analysis of structure-activity relationship and protein-ligand interaction fingerprints provides insights for the design strategies of DPP-4 inhibitors.
Approved and potent reported dipeptidyl peptidase-4 (DPP-4) inhibitors with gliptin-like structures are classified here according to their structures and mechanisms of the inhibition in three groups: (i) those with pyrrolidine or analogs as P1 fragment with alpha-aminoacyl linker, (ii) structures with trifluorophenyl moiety or analogs as P1 fragment with beta-aminobutanoyl linker, and (iii) DPP-4 inhibitors with pyrimidine-2,4-dione or analogs as P1' fragment. The structure-activity relationship analysis was performed for those whose cocrystallized structures with the enzyme were published. While inhibitors with pyrrolidine and trifluorophenyl moiety or analogs as P1 fragment bind in a similar way in S1, S2 and S2 extensive domains of the enzyme, the binding mode of pyrimidine-2,4-dione derivatives/analogs differs with additional interactions in S1' and S2' pockets. Three general schemes of fragmented gliptins and gliptin-like structures with the enzyme and protein-ligand interaction fingerprints were made, which might be useful in the creation of DPP-4 inhibitor's design strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据